Ocrelizumab versus ofatumumab efficacy and safety after natalizumab discontinuation in multiple sclerosis: a retrospective real-world comparison
Academic Article
Publication Date:
2026
Short description:
Ocrelizumab versus ofatumumab efficacy and safety after natalizumab discontinuation in multiple sclerosis: a retrospective real-world comparison / Marino, V., Moiola, L., Zanetta, C., Rubin, M., Rossi, L., Margoni, M., Nozzolillo, A., Gattuso, I., Viti, V., Petza, E., Rocca, M.A., Guerrieri, S., Filippi, M.. - In: JOURNAL OF NEUROLOGY. - ISSN 0340-5354. - 273:10(2026). [10.1007/s00415-026-14124-1]
Iris type:
1.1.2. Articolo in Rivista - Letter, Note
List of contributors:
Marino, V.; Moiola, L.; Zanetta, C.; Rubin, M.; Rossi, L.; Margoni, M.; Nozzolillo, A.; Gattuso, I.; Viti, V.; Petza, E.; Rocca, M. A.; Guerrieri, S.; Filippi, M.
Published in: